Steven Cohen’s Amedisys AMED Stock Holding History

Steven Cohen’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-200,000	Closed	-$12.6M	–	861
2017 Q2	$12.6M	Buy	+200,000	New	+$11.6M	0.07%	344

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Steven Cohen's AMED Position: Q1 2023 in Review

Steven Cohen sold out of Amedisys (AMED) in Q1 2023, closing a stake of 551,468 shares — an estimated $46.1M sold.

Steven Cohen first reported a position in AMED in Q3 2014 and held it in 16 quarters. The position peaked at $104M in Q3 2022. 282 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

Steven Cohen reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
Steven Cohen sold 551,468 Amedisys shares in Q1 2023, an estimated $46.1M.
Steven Cohen first reported a position in Amedisys in Q3 2014 and held it in 16 quarters.
Steven Cohen's Amedisys position peaked at $104M in Q3 2022.
282 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Point72 Asset Management's 13F filing for Q1 2023, filed 15 May 2023.